Prolonged Vastus Lateralis Denervation After Botulinum Toxin Type A Injection

被引:5
作者
Dunne, John W. [1 ,2 ]
Singer, Barbara J. [1 ]
Silbert, Peter L. [1 ,2 ]
Singer, Kevin P. [1 ]
机构
[1] Univ Western Australia, Sch Surg, Ctr Musculoskeletal Studies, Perth, WA 6000, Australia
[2] Royal Perth Hosp, Dept Neurol, Perth, WA, Australia
关键词
botulinum A toxin; muscle denervation; electromyography; neuromuscular blockade; MUSCLE; DYSPORT(R); TERMINALS;
D O I
10.1002/mds.22852
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Intramuscular injection of botulinum toxin (BoNT) produces reversible blockade of neuromuscular transmission. In animal experimental models, recovery begins within four weeks and is usually complete by twelve weeks. We present evidence of prolonged denervation following BoNT injection of the vastus lateralis (VL) muscle to correct quadriceps muscle imbalance in patients with chronic anterior knee pain. Needle electromyography data were obtained from 10 subjects who had received a single BoNT treatment 5 to 19 months earlier as part of a clinical trial. Insertional and spontaneous activity, recruitment, and motor unit action potentials were examined. Clear differences between the injected and non-injected VL muscles, which correlated with the time since injection, were identified in all subjects. All 10 subjects studied with needle EMG showed evidence of persisting denervation in the BoNT-A injected VL muscle beyond the period of neuromotor recovery expected from animal experimental studies. (C) 2010 Movement Disorder Society
引用
收藏
页码:397 / 401
页数:5
相关论文
共 50 条
  • [31] Botulinum toxin type B in piriformis syndrome
    Lang, AM
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2004, 83 (03) : 198 - 202
  • [32] Botulinum toxin type A and EMG: A key to the understanding of chronic tension-type headaches?
    Rollnik, JD
    Karst, M
    Fink, M
    Dengler, R
    HEADACHE, 2001, 41 (10): : 985 - 989
  • [33] Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction
    Kelly, Elizabeth A.
    Koszewski, Ian J.
    Jaradeh, Safwan S.
    Merati, Albert L.
    Blumin, Joel H.
    Bock, Jonathan M.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2013, 122 (02) : 100 - 108
  • [34] Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction
    Wei, Pengxu
    TOXINS, 2022, 14 (05)
  • [35] Injection techniques for botulinum toxin using electromyography and electrical stimulation
    O'Brien, CF
    EUROPEAN JOURNAL OF NEUROLOGY, 1997, 4 : S47 - S50
  • [36] Ultrasound and Electromyography Guidance for Injection of the Longus Colli With Botulinum Toxin for the Treatment of Cervical Dystonia
    Allison, Stephen K.
    Odderson, Ib R.
    ULTRASOUND QUARTERLY, 2016, 32 (03) : 302 - 306
  • [37] The Anatomical Basis of Paradoxical Masseteric Bulging after Botulinum Neurotoxin Type A Injection
    Lee, Hyung-Jin
    Kang, In-Won
    Seo, Kyle K.
    Choi, You-Jin
    Kim, Seong-Taek
    Hu, Kyung-Seok
    Kim, Hee-Jin
    TOXINS, 2017, 9 (01):
  • [38] An Anatomical Perspective to Botulinum Toxin Injection of Flexor Digitorum Profundus
    Campisi, Emma Stefanie
    Khan, Omar
    Agur, Anne Marie Reet
    Reebye, Rajiv
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2025, 52 (01) : 145 - 146
  • [39] Central origin of the antinociceptive action of botulinum toxin type A
    Bach-Rojecky, Lidija
    Lackovic, Zdravko
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 94 (02) : 234 - 238
  • [40] Botulinum Toxin Type A: Assessing The Effects on The Brain Stem
    Seymen, Cemile Merve
    Tuncer, Serhan
    Ayhan, M. Suhan
    Elmas, Cigdem
    AESTHETIC PLASTIC SURGERY, 2018, 42 (02) : 538 - 545